5 |
골대사 |
혈관 및 판막의 석회화와 수질 및 피질골의 골밀도의 상관성
QCT Volumetric Bone Mineral Density and Vascular and Valvular Calcification: The Framingham Study
Jimmy J Chan,1 L Adrienne Cupples,2,3 Douglas P Kiel,4,5,6 Christopher J O’Donnell,3,4,7 Udo Hoffmann,4,7 and Elizabeth J Samelson4,5,6 1 Albert Einstein College of Medicine, Bronx, NY, USA 2 Boston University School of Public Health, Boston, MA, USA 3 National Heart, Lung, and Blood Institute’s Framingham Heart Study, Framingham, MA, USA 4 Harvard Medical School, Boston, MA, USA 5 Institute for Aging Research, Hebrew SeniorLife, Boston, MA USA 6 Beth Israel Deaconess Medical Center, Boston, MA, USA 7 Massachusetts General Hospital, Boston, MA, USA
J Bone Miner Res 2015 Oct;30(10):1767-74
|
4 |
골대사 |
갑상선기능저하증에서의 주요 골다공증 골절 위험인자
The Excess Risk of Major Osteoporotic Fractures in Hypothyroidism Is Driven by Cumulative Hyperthyroid as Opposed to Hypothyroid Time: An Observational Register-Based Time-Resolved Cohort Analysis
J Bone Miner Res. 2015 May;30(5):898-905.
|
3 |
골대사 |
출산 후 수유중인 여성에서의 골미세구조의 변화
(Changes in cortical volumetric bone mineral density and thickness, and trabecular thickness in lactating women postpartum)
J Clin Endocrinol Metab. 2015 Feb;100(2):535-43
|
2 |
골대사 |
폐경후 골감소증 여성에서 sclerostin 항체인 blosozumab의 무작위 이중맹검 2상 임상 시험(A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral density)
J Bone Miner Res 2014 Aug 28, Epub ahead of print
|
1 |
골대사 |
만성 신질환 환자에서 혈중 sclerostin과 심혈관계 예후의 관계
(Serum sclerostin and adverse outcomes in non-dialyzed chronic kidney disease patients)
J. Clin. Endocrinol. Metab.
http://dx.doi.org/10.1210/jc.2014-2042 [Epub ahead of print]
|